Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/includes/bootstrap.inc).

Marapharm Ventures Inc. 'Marapharm' Provides Updates on Construction of Cannabis Facilities

Ticker: 
Specialties: 
Cannabis,
Facilities
submitted by /u/sanghs [link] [comments]Read more

ChineseInvestors.com Featured in New Interview with SmallCapVoice.com

07/25/2017
Ticker: 
Specialties: 
Investors
AUSTIN, Texas, July 25, 2017-- SmallCapVoice.com, Inc. and ChineseInvestors.com, the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known cannabidiol ...Read more

Abattis Expands and Strengthens Its Asian Distribution Sales Channels

07/25/2017
Ticker: 
Specialties: 
Bioceuticals,
Development,
Distribution
Vancouver, British Columbia--(Newsfile Corp. - July 25, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the appointment of Mr. Wei Ma to oversee export and business development in Asia, in an effort to further expand and strengthen the Company's Asian distribution channels.Mr. Ma has over 15 years of experience in international trade, with a focus on importing and exporting in Asia. His deep understanding and ...Read more

Aphria's Q4 Investors Deck

07/25/2017
Ticker: 
Specialties: 
Management,
Investors,
Retail Sales
https://aphria.com/wp-content/uploads/2017/01/Q4_2017_Aphria_InvestorDeck_PIXELATED.pdf [No change in completion dates for Phase III or IV] Slide 11 Two Pronged Sales Strategy. Interesting points: Retail: Highly profitable (~70% margin with 30% cost below the line) Wholesale: (~50% Margin but no costs below line.) Example Agreement in Place: Scientus Pharma Committed 1/8th of Phase II expansion. Capacity for bulk sales of full plants (27,000 plants over 12 months). 70-75% Margin So Phase II is incrementally 6500 annual kgs. Or 1,625 kg more per Q. 2,250 per Q cumulative. They sold 738 kgs...Read more

Aphria's Q4 Investors Deck - New item of Note

Ticker: 
Specialties: 
Management,
Investors,
Retail Sales
https://aphria.com/wp-content/uploads/2017/01/Q4_2017_Aphria_InvestorDeck_PIXELATED.pdf [No change in completion dates for Phase III or IV] Slide 11 Two Pronged Sales Strategy. Interesting points: Retail: Highly profitable (~70% margin with 30% cost below the line) Wholesale: (~50% Margin but no costs below line.) Example Agreement in Place: Scientus Pharma Committed 1/8th of Phase II expansion. Capacity for bulk sales of full plants (27,000 plants over 12 months). 70-75% Margin So Phase II is incrementally 6500 annual kgs. Or 1,625 kg more per Q. 2,250 per Q cumulative. They sold 738 kgs...Read more

AbbVie Several Candidates to Replace Humira in the Pipeline

07/25/2017
Ticker: 
Specialties: 
News,
Research
NEW YORK, NY / ACCESSWIRE / July 25th, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...Read more

Endexx to Showcase Phyto-Bites at the 4th Annual SuperZoo Show 2017 in Las Vegas

07/25/2017
Ticker: 
Specialties: 
Food,
Products
Endexx Corporation , a provider of innovative phyto-nutrient-based food and nutritional products, announced today it will be attending the SuperZoo Show held on July 25-27, 2017 at the Mandalay Bay Convention ...Read more

Hydropothecary has new product, Cannabis Oil Sublingual Mist. Elixir No. 1

07/25/2017
Specialties: 
Cannabis
submitted by /u/w2211 [link] [comments]Read more

Hydropothecary has new product, Cannabis Oil Sublingual Mist. Elixir No. 1

Specialties: 
Cannabis
submitted by /u/w2211 [link] [comments]Read more

Why is OGI's upcoming earnings report not on the upcoming events ticker??

07/25/2017
Specialties: 
Events
submitted by /u/RodneyGK [link] [comments]Read more

Pages